Business

Former Starbucks CEO Howard Schultz has shared his thoughts on the recent disappointing performance of the coffee chain. He believes that Starbucks can make a comeback by focusing on improving its U.S. stores. Schultz emphasized the need for enhancing the mobile order and pay experience, as well as revamping the creation of new drinks to
0 Comments
Skydance Media, backed by private equity firms RedBird Capital and KKR, is facing a crucial decision regarding its offer for Paramount Global. The company is demanding a solid commitment from controlling shareholder Shari Redstone, or it may walk away from the deal entirely. With a deadline looming and no intention of extending the exclusivity window,
0 Comments
Warren Buffett’s Berkshire Hathaway has been quietly making a significant wager on the financial industry over the past year. This confidential bet, likely to be disclosed at the company’s annual shareholder meeting in Omaha, Nebraska, has sparked curiosity among investors. Buffett, known for his investing prowess, may choose to explain his rationale behind this move
0 Comments
Wayfair, the online furniture retailer, recently reported its first-quarter results, showing mixed performance trends. Despite a decrease in sales, the company managed to reduce its losses after implementing significant cost-cutting measures. This move resulted in a better-than-expected financial outcome, beating Wall Street’s projections both in terms of revenue and loss per share. During the first
0 Comments
With the continued rise of inflation impacting consumer spending, Walmart has introduced a new private label grocery brand called BetterGoods. This brand is aimed at offering customers more trendy and chef-driven food options at affordable prices, with most items priced at under $5. As the largest grocer by revenue in the United States, Walmart is
0 Comments
A federal judge in New Jersey recently made a decision that rejected the legal challenges presented by Johnson & Johnson and Bristol Myers Squibb concerning the Biden administration’s Medicare drug price negotiations. This ruling marked a significant victory for the Biden administration in an ongoing legal battle with multiple pharmaceutical companies over the pricing negotiations.
0 Comments
The Food and Drug Administration recently gave the green light to Pfizer’s groundbreaking treatment for hemophilia B, marking the company’s first-ever gene therapy to receive approval in the United States. This approval is a significant milestone in the field of genetic treatments and offers a promising solution for individuals suffering from this rare genetic bleeding
0 Comments